Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Marie Skłodowska-Curie Action · Running

STRIKE Comprehensive STRategIes to tacKlE malignant tumors: from nanomedicine and theranostics to precision medicine

Coordinator
Universita Degli Studi Di Messina, Italy
Runs
1 January 2023 to 31 December 2026
Status
Running
EU funding
€2.1m
Total cost
—
Partners
12 organisations in 8 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101072462

What the project is doing

In the project's own words, from its summary on CORDIS.

STRIKE-DN will raise excellence in research and training in nanomedicine/precision medicine creating new generation of entrepreneurial and innovative multidisciplinary doctoral candidates. New experimental aspects on design and synthesis of nanostructured magnetic materials will be applied to the development of innovative magnetic field-responsive nanotherapeutics for osteosarcoma (OS) combinational therapy. Moreover, the peculiar features of STRIKE nanomaterials will be exploited for liquid biopsy using biological samples of BRCA+ breast cancer (BC) patients.

The cooperation among outstanding universities, research institutes and industries will provide the DCs with trans-national exchanges and the most innovative research trainings in novel anticancer therapeutic strategies, including in vivo biological evaluation, imaging in OS and early diagnosis in BC. STRIKE will provide enhanced career perspectives in academic and non-academic sectors for 8 DCs in highly innovative fields by interdisciplinary mobility among 12 institutes/companies in 8 EU countries.

STRIKE aims to: 1) develop 8 highly skilled employable doctoral candidates; 2) enhance interdisciplinary capacity and cooperation within the EU nanomedicine and precision medicine research networks; 3) strengthen EU’s competitiveness and growth in nanomedicine and precision medicine through the translation of the consortium research/innovation outputs. The consortium will fulfill its goals through: a) achieving research excellence; b) providing a complete cutting edge research and innovation training program with some of the European top research institutes and industry partners; c) hosting interdisciplinary and commercial workshops, seminars and outreach events; d) maximizing knowledge transfer using Open Science and patents; e) delivering highly trained professionals, whose profiles fit within the requirements of academia, industry and public/private institutions, fostering their employability and promoting the innovation of EU research.

Topics

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di MessinaMessinaItalyCoordinator
Medizinische Universitaet WienWienAustriaParticipant
Univerzita Palackeho V OlomouciOlomoucCzechiaParticipant
Wiley-Vch Verlag GmbH & Co KgaaWeinheimGermanyAssociatedpartner
Nanotech Solutions Sociedad LimitadaVillacastinSpainParticipant
Universidad Autonoma De MadridMadridSpainAssociatedpartner
Nantes UniversiteNantesFranceParticipant
Cyclolab Ciklodextrin Kutato-Fejleszto KftBudapestHungaryAssociatedpartner
National University of Ireland MaynoothMaynoothIrelandParticipant
Consiglio Nazionale Delle RicercheRomaItalyParticipant
Consortium for Genomic Technologies Societa Benefit SRLMilanItalyParticipant
Stem Innovation SRLRomaItalyAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI